Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NYSE:HIMS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.61+1.7%$2.46$1.58▼$3.92$1.87B2.446.98 million shs6.93 million shsHIMSHims & Hers Health$23.79+0.2%$24.01$13.74▼$70.43$5.50B2.4322.49 million shs16.38 million shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments0.00%+4.72%+46.09%+76.62%+11.29%HIMSHims & Hers Health0.00%+6.55%-22.57%+53.63%-56.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.61+1.7%$2.46$1.58▼$3.92$1.87B2.446.98 million shs6.93 million shsHIMSHims & Hers Health$23.79+0.2%$24.01$13.74▼$70.43$5.50B2.4322.49 million shs16.38 million shs10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments0.00%+4.72%+46.09%+76.62%+11.29%HIMSHims & Hers Health0.00%+6.55%-22.57%+53.63%-56.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.00Hold$2.90-19.67% DownsideHIMSHims & Hers Health 2.12Hold$28.7020.64% UpsideCurrent Analyst Ratings BreakdownLatest CLOV and HIMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$28.00 ➝ $25.005/22/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$23.005/22/2026HIMSHims & Hers Health Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$18.00 ➝ $23.005/19/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$30.00 ➝ $28.005/13/2026HIMSHims & Hers Health Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$32.00 ➝ $30.005/12/2026HIMSHims & Hers Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Sell (D)5/12/2026HIMSHims & Hers Health Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$24.505/12/2026HIMSHims & Hers Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$35.005/12/2026HIMSHims & Hers Health Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.005/12/2026HIMSHims & Hers Health CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$24.00 ➝ $28.003/27/2026CLOVClover Health Investments Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 5/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.92B0.99N/AN/A$0.64 per share5.64HIMSHims & Hers Health$2.35B2.35$0.84 per share28.38$1.93 per share12.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$85.55M-$0.12N/AN/AN/A-2.58%-16.52%-9.28%8/4/2026 (Estimated)HIMSHims & Hers Health$128.37M-$0.09N/A48.5546.09-0.56%6.10%1.52%8/10/2026 (Estimated)Latest CLOV and HIMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q1 2026HIMSHims & Hers Health$0.04-$0.40-$0.44-$0.40$616.84 million$608.10 million5/6/2026Q1 2026CLOVClover Health Investments$0.07$0.05-$0.02$0.05$714.89 million$749.19 million2/26/2026Q4 2025CLOVClover Health Investments-$0.05-$0.10-$0.05-$0.10$467.06 million$487.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.331.33HIMSHims & Hers Health2.181.691.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%HIMSHims & Hers Health63.52%Insider OwnershipCompanyInsider OwnershipCLOVClover Health Investments23.51%HIMSHims & Hers Health11.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680526.68 million402.86 millionOptionableHIMSHims & Hers Health2,442231.46 million201.13 millionOptionableCLOV and HIMS HeadlinesRecent News About These CompaniesHims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofAMay 26 at 5:38 PM | proactiveinvestors.comHims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofAMay 26 at 3:02 PM | proactiveinvestors.comHims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofAMay 26 at 2:55 PM | proactiveinvestors.comBank of America Cuts Hims & Hers Health (NYSE:HIMS) Price Target to $25.00May 26 at 2:14 PM | marketbeat.comHere is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending StockMay 26 at 10:01 AM | zacks.comHims & Hers Health, Inc. (NYSE:HIMS) Given Average Rating of "Hold" by AnalystsMay 25 at 2:30 AM | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Given Average Recommendation of "Hold" by AnalystsMay 25 at 2:29 AM | marketbeat.comHims & Hers CEO is plotting new ways to upend traditional health careMay 24 at 9:37 AM | washingtonpost.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)May 23 at 12:38 PM | theglobeandmail.comHims & Hers Health, Inc. $HIMS Shares Sold by Steadview Capital Management LLCMay 23 at 6:31 AM | marketbeat.comTruist Financial Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock PriceMay 23 at 3:51 AM | americanbankingnews.comHims & Hers issues convertible notes and capped callsMay 23 at 1:10 AM | theglobeandmail.comHims & Hers Deepens Personalized Care Through Platform ExpansionMay 22, 2026 | finance.yahoo.comHims & Hers Health (NYSE:HIMS) Price Target Raised to $23.00May 22, 2026 | marketbeat.comHims & Hers Deepens Personalized Care Through Platform ExpansionMay 22, 2026 | zacks.comHIMS Stock Extends 3-Day Rally: Hims & Hers Targets GLP-1 Gold Rush In Canada After Novo Nordisk Patent ExpiryMay 22, 2026 | stocktwits.comSFortis Group Advisors LLC Has $994,000 Holdings in Hims & Hers Health, Inc. $HIMSMay 22, 2026 | marketbeat.comHims & Hers Health to Sell Generic GLP-1 Drugs in CanadaMay 21, 2026 | marketwatch.comHims & Hers launches generics for Novo’s semaglutide in CanadaMay 21, 2026 | msn.comThe Silver Lining of Last Week's Hims & Hers Earnings Miss...May 21, 2026 | marketbeat.comHims offers Apotex's generic semaglutide in Canada after Novo patent expiryMay 21, 2026 | reuters.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusBy Jessica Mitacek | May 8, 2026Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?By Jessica Mitacek | May 12, 2026The Silver Lining of Last Week's Hims & Hers Earnings MissBy Jessica Mitacek | May 21, 2026Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansBy Leo Miller | April 28, 2026CLOV and HIMS Company DescriptionsClover Health Investments NASDAQ:CLOV$3.61 +0.06 (+1.69%) As of 04:00 PM EasternClover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Hims & Hers Health NYSE:HIMS$23.79 +0.04 (+0.17%) As of 03:58 PM EasternHims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AutoZone's Pullback Sets Up a Long-Term Buying Opportunity AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026 Quantum Stocks Just Got a Lifeline—Who Benefits Most? Why BJ’s Wholesale Club Stock Could Be Ready for a Rebound 5 High-Yield Stocks and ETFs to Buy and Hold for the Next Decade Rocket Companies Turns Around, But Mortgage Risk Remains After NVIDIA, Broadcom's Earnings Are Next—Here's What to Watch Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
